Ju‐Hee Bang
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in
- Oncology 14
- HER2/EGFR in Cancer Research 4
- Cancer Immunotherapy and Biomarkers 3
- Pancreatic and Hepatic Oncology Research 3
- PARP inhibition in cancer therapy 3
-
- Chronic Myeloid Leukemia Treatments 9
- Co-authors
- Ah‐Rong Nam (28 shared papers)Do‐Youn Oh (28 shared papers)Yung‐Jue Bang (17 shared papers)Ji Eun Park (9 shared papers)Mei Hua Jin (8 shared papers)Tae‐Yong Kim (11 shared papers)Kyung-Hun Lee (7 shared papers)Seock‐Ah Im (6 shared papers)
- Journals
- Cancer Research and Treatment (8 papers)Blood (6 papers)Gastric Cancer (5 papers)Cell Communication and Signaling (3 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- South KoreaUnited StatesThailand
In The Last Decade
Ju‐Hee Bang
38 papers receiving 788 citations
Peers
Comparison fields: 5 of 47
- Oncology 317
- Hematology 159
- Surgery 169
- Pulmonary and Respiratory Medicine 95
- Cancer Research 20
Countries citing papers authored by Ju‐Hee Bang
This map shows the geographic impact of Ju‐Hee Bang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Hee Bang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Hee Bang more than expected).
Fields of papers citing papers by Ju‐Hee Bang
This network shows the impact of papers produced by Ju‐Hee Bang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Hee Bang. The network helps show where Ju‐Hee Bang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju‐Hee Bang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 90 | |
| 2 | 2016 | 79 | |
| 3 | 2013 | 53 | |
| 4 | 2016 | 53 | |
| 5 | 2017 | 51 | |
| 6 | 2012 | 43 | |
| 7 | 2019 | 32 | |
| 8 | 2018 | 28 | |
| 9 | 2021 | 28 | |
| 10 | 2019 | 27 | |
| 11 | 2019 | 26 | |
| 12 | 2021 | 21 | |
| 13 | 2020 | 20 | |
| 14 | 2012 | 19 | |
| 15 | 2024 | 18 | |
| 16 | 2014 | 17 | |
| 17 | 2015 | 16 | |
| 18 | 2018 | 14 | |
| 19 | 2019 | 14 | |
| 20 | 2011 | 13 |
About Ju‐Hee Bang
Ju‐Hee Bang is a scholar working on Oncology, Hematology, Surgery, Pulmonary and Respiratory Medicine and Cell Biology, having authored 38 papers that have together received 794 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Chronic Myeloid Leukemia Treatments (9 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), PARP inhibition in cancer therapy (3 papers), Gastric Cancer Management and Outcomes (3 papers) and interferon and immune responses (1 paper). The work is most often cited by research in Oncology (317 citations), Hematology (159 citations), Surgery (169 citations), Pulmonary and Respiratory Medicine (95 citations) and Cancer Research (20 citations). Ju‐Hee Bang has collaborated with scholars based in South Korea, United States and Thailand. Frequent co-authors include Ah‐Rong Nam, Do‐Youn Oh, Yung‐Jue Bang, Ji Eun Park, Mei Hua Jin, Tae‐Yong Kim, Kyung-Hun Lee, Seock‐Ah Im, Sae‐Won Han and Hyerim Ha. Their work appears in journals such as Cancer Research and Treatment, Blood, Gastric Cancer, Cell Communication and Signaling and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.